Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Levy

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Transplantation Proceedings|March 26, 2004
Neoral C2 monitoring in solid organ transplantationG A Levy
Gastroenterologia Y Hepatologia|April 27, 2002
New strategies to optimize clinical outcomes with cyclosporine in liver transplantationG A Levy
Transplantation Proceedings|May 18, 2000
Neoral use in the liver transplant recipientG A Levy
Transplantation Proceedings|September 2, 1998
Neoral is superior to FK 506 in liver transplantationG A Levy
Transplantation Proceedings|December 26, 2001
Neoral C(2) in liver transplant recipientsG A Levy
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 4, 1999
Neoral/cyclosporine-based immunosuppressionG A Levy
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 2, 2001
Long-term immunosuppression and drug interactionsG A Levy
Transplantation Proceedings|May 20, 1999
Relationship of pharmacokinetics to clinical outcomesG A Levy
Transplantation Proceedings|August 1, 1996
Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to NeoralG A Levy
Transplantation Proceedings|August 1, 1996
Neoral therapy in liver transplantationG A Levy
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Transplantation Proceedings|March 26, 2004
Neoral C2 monitoring in solid organ transplantationG A Levy
Gastroenterologia Y Hepatologia|April 27, 2002
New strategies to optimize clinical outcomes with cyclosporine in liver transplantationG A Levy
Transplantation Proceedings|May 18, 2000
Neoral use in the liver transplant recipientG A Levy
Transplantation Proceedings|September 2, 1998
Neoral is superior to FK 506 in liver transplantationG A Levy
Transplantation Proceedings|December 26, 2001
Neoral C(2) in liver transplant recipientsG A Levy
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 4, 1999
Neoral/cyclosporine-based immunosuppressionG A Levy
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 2, 2001
Long-term immunosuppression and drug interactionsG A Levy
Transplantation Proceedings|May 20, 1999
Relationship of pharmacokinetics to clinical outcomesG A Levy
Transplantation Proceedings|August 1, 1996
Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to NeoralG A Levy
Transplantation Proceedings|August 1, 1996
Neoral therapy in liver transplantationG A Levy
Pageof 16